药物敏感型活动性肺结核的医学管理：检查、影像学表现及治疗
Medical management of drug-sensitive active thoracic tuberculosis: the work-up, radiographic findings and treatment.
作者信息
Eddy Jared, Khan Taimur, Schembri Frank
机构信息
Department of Infectious Diseases, Boston University School of Medicine, Boston, MA, USA.
Pulmonary Center, Boston University School of Medicine, Boston, MA, USA.
出版信息
J Thorac Dis. 2018 Oct;10(Suppl 28):S3378-S3391. doi: 10.21037/jtd.2018.08.84.
Abstract
Tuberculosis (TB) infection and disease have plagued human civilization across time and led to immeasurable morbidity and mortality. This review article focuses on the most currently available information regarding the diagnostic workup, radiologic presentation and treatment of drug-sensitive active TB. As discussed, if adequate resources and methods are available to diagnose, evaluate, and treat patients, drug sensitive TB is an imminently curable disease.
摘要
结核病感染与疾病长期以来一直困扰着人类文明，导致了难以估量的发病率和死亡率。这篇综述文章聚焦于目前有关药物敏感型活动性结核病的诊断检查、影像学表现及治疗的最新信息。如文中所讨论的，如果有足够的资源和方法来诊断、评估及治疗患者，那么药物敏感型结核病是一种可迅速治愈的疾病。
相似文献
1
Medical management of drug-sensitive active thoracic tuberculosis: the work-up, radiographic findings and treatment.
J Thorac Dis. 2018 Oct;10(Suppl 28):S3378-S3391. doi: 10.21037/jtd.2018.08.84.
3
Tuberculosis in kidney transplant recipients: A case series.
World J Transplant. 2017 Jun 24;7(3):213-221. doi: 10.5500/wjt.v7.i3.213.
4
[Recent progress in mycobacteriology].
Kekkaku. 2007 Oct;82(10):783-99.
5
Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (TB) and its role in the detection of latent TB infection: a systematic review.
J Rheumatol Suppl. 2014 May;91:32-40. doi: 10.3899/jrheum.140100.
6
Update on trends in childhood tuberculosis.
Curr Opin Pediatr. 2018 Feb;30(1):152-160. doi: 10.1097/MOP.0000000000000581.
7
Extensively Drug-Resistant Tuberculosis: Principles of Resistance, Diagnosis, and Management.
Mayo Clin Proc. 2016 Apr;91(4):482-95. doi: 10.1016/j.mayocp.2016.01.014. Epub 2016 Feb 20.
8
Infection caused by Mycobacterium tuberculosis.
Ann Pharmacother. 1994 Jan;28(1):72-84. doi: 10.1177/106002809402800115.
9
[The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
Kekkaku. 2009 Apr;84(4):203-11.
10
Trends in Diagnosis for Active Tuberculosis Using Nanomaterials.
Curr Med Chem. 2019;26(11):1946-1959. doi: 10.2174/0929867325666180912105617.
引用本文的文献
1
Advances in the Diagnosis of Latent Tuberculosis Infection.
Infect Drug Resist. 2025 Jan 25;18:483-493. doi: 10.2147/IDR.S504632. eCollection 2025.
2
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis.
Ann Transl Med. 2020 Sep;8(18):1143. doi: 10.21037/atm-20-5964.
3
Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report.
Adv Prev Med. 2019 Jun 20;2019:5181847. doi: 10.1155/2019/5181847. eCollection 2019.
本文引用的文献
1
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.
Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.
2
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. eCollection 2016 Oct.
3
Tuberculosis Diagnostics: State of the Art and Future Directions.
Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0019-2016.
4
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566.
5
False-positive Xpert(®) MTB/RIF assays and previous treatment.
Int J Tuberc Lung Dis. 2015 Apr;19(4):495-6. doi: 10.5588/ijtld.14.0800-2.
6
A four-month gatifloxacin-containing regimen for treating tuberculosis.
N Engl J Med. 2014 Oct 23;371(17):1588-98. doi: 10.1056/NEJMoa1315817.
7
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7.
8
Therapeutic drug monitoring in the treatment of tuberculosis: an update.
Drugs. 2014 Jun;74(8):839-54. doi: 10.1007/s40265-014-0222-8.
9
Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen.
Respir Med. 2014 Apr;108(4):654-9. doi: 10.1016/j.rmed.2014.01.010. Epub 2014 Jan 27.
10
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Lancet Respir Med. 2013 Aug;1(6):462-70. doi: 10.1016/S2213-2600(13)70119-X. Epub 2013 Jul 1.
Zotero 插件